KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) Equity Average (2016 - 2025)

Historic Equity Average for Biolife Solutions (BLFS) over the last 15 years, with Q3 2025 value amounting to $350.4 million.

  • Biolife Solutions' Equity Average rose 834.61% to $350.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $350.4 million, marking a year-over-year increase of 834.61%. This contributed to the annual value of $343.3 million for FY2024, which is 217.7% down from last year.
  • Latest data reveals that Biolife Solutions reported Equity Average of $350.4 million as of Q3 2025, which was up 834.61% from $349.9 million recorded in Q2 2025.
  • Over the past 5 years, Biolife Solutions' Equity Average peaked at $483.7 million during Q4 2021, and registered a low of $206.6 million during Q1 2021.
  • Moreover, its 5-year median value for Equity Average was $350.4 million (2025), whereas its average is $366.9 million.
  • Its Equity Average has fluctuated over the past 5 years, first surged by 28089.91% in 2021, then tumbled by 2429.74% in 2023.
  • Over the past 5 years, Biolife Solutions' Equity Average (Quarter) stood at $483.7 million in 2021, then fell by 20.47% to $384.7 million in 2022, then fell by 12.95% to $334.8 million in 2023, then grew by 0.7% to $337.2 million in 2024, then increased by 3.93% to $350.4 million in 2025.
  • Its last three reported values are $350.4 million in Q3 2025, $349.9 million for Q2 2025, and $350.8 million during Q1 2025.